期刊文献+

多西他赛Pluronic F68聚合物胶束的制备与体外评价 被引量:6

Docetaxel-loaded Pluronic F68 polymeric micelles: preparation and in vitro evaluation
原文传递
导出
摘要 目的制备多西他赛(DTX)的普朗尼克F68(Pluronic F68)聚合物胶束,并对其理化性质进行研究。方法采用纳米沉淀法制备DTX胶束,以L9(34)正交实验优化处方;高效液相色谱法测定药物的含量;通过透射电镜观察DTX胶束的形态,并进行粒度分布和zeta电位的测定;采用动态膜透析法考察DTX胶束的体外释药行为。结果 DTX胶束的包封率为(89.10±1.50)%,载药量为(0.060±0.003)%,外观形态呈现球形或类球形,粒径为(135.1±3.42)nm,zeta电位为(-10.56±3.52)mV。体外释放结果显示DTX胶束具有一定的缓释能力。结论利用纳米沉淀法成功制备了DTX胶束,成型好,粒径小,改善了DTX的溶解性。 Objective To prepare docetaxel(DTX)-loaded Pluronic F68 polymeric micelles(DTX-micelles) and evaluate their physicochemical characterization.Methods The DTX-micelles were prepared by nano-precipitation methods.Based on the results of single factor experiments,the DTX-micelle formulation was optimized by orthogonal design.The encapsulation efficacy(EE%) and drug loading(DL%) were determined by the RP-HPLC method.The physicochemical characteristics were evaluated,including surface morphology,particle size and size distribution as well as zeta potential.The in vitro release behaviors of DTX-micelles were carried out by the dynamic membrane dialysis technique.Results The drug-loading rate and entrapment rate were(0.060±0.003)% and(89.10±1.50)%,respectively.The DTX-micelles were spherical with a mean particle size of(135.1±3.42) nm and a zeta potential of(-10.56±3.52)mV.The release of DTX from DTX-micelles followed the Weibull equation.Conclusions DTX-micelles were successfully prepared and improved the solubility of DTX.
出处 《山东大学学报(医学版)》 CAS 北大核心 2011年第11期156-160,共5页 Journal of Shandong University:Health Sciences
关键词 多西他赛 普朗尼克F68 聚合物胶束 纳米沉淀法 Docetaxel Pluronic F68 Polymeric micelles Nano-precipitation methods
  • 相关文献

参考文献8

  • 1Pazdur R, Kudelka A P, Kavanagh J J, et al. The taxoids : paclitaxel ( Taxol ) and docetaxel ( Taxotere )[J]. Cancer Treat Rev, 1993, 19(4) :351-386.
  • 2Cortes J E, Pazdur R. Docetaxel [J ]. J Clin Oncol, 1995, 13 (10) :2643-2655.
  • 3Musumeci T, Ventura C A, Giannone I, et al. PLA/PL- GA nanoparticles for sustained release of docetaxel [ J ]. Int J Pharm, 2006, 325(1-2) : 172-179.
  • 4Yokoyama M. Polymeric micelles as a new drug carrier system and their required considerations for clinical trials [J]. Expert Opin Drug Deliv, 2010, 7(2) : 145-158.
  • 5Mu C F, Balakrishnan P, Cui F D, et al. The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel [J]. Biomaterials, 2010, 31(8): 2371-2379.
  • 6赵丽娟,刘东华,刘志红,刘海霞,张娜.多西他赛Pluronic F127聚合物胶束的制备与表征[J].中国生化药物杂志,2011,32(2):107-110. 被引量:9
  • 7Yin Y M, Cui F D, Mu C F, et al. Docetaxel microe- mulsion for enhanced oral bioavallability: preparation and in vitro and in vivo evaluation [ J ]. J Control Release, 2009, 140(2): 86-94.
  • 8Gaucher G, Dufresne M H, Sant V P, et al. Block copol- ymer micelles: preparation, characterization and applica- tion in drug delivery [J]. J Control Release, 2005, 109 (1-3): 169-188.

二级参考文献11

共引文献8

同被引文献96

  • 1寸冬梅,崔福德,关颖,陶安进.乳酸-羟基乙酸共聚物微球中蜂毒包封率的测定[J].中国药学杂志,2005,40(2):120-122. 被引量:2
  • 2李欣,刘燕,康艳敏,梅兴国.高效液相色谱法测定多西紫杉醇静脉纳米乳剂的含量[J].解放军药学学报,2007,23(1):32-34. 被引量:6
  • 3甘良春,侯世祥,毕岳琦,王昶光,王新春,陈其翔.2种方法制备丹参酮Ⅱ_A-PLGA纳米粒的比较[J].中国中药杂志,2007,32(7):578-581. 被引量:6
  • 4ABDELWAHED W, DEGONBERT G, STAINMESSE S, et al. Freeze-drying of nanoparticles: formulation, process and storage considerations[J] Adv Drug Deliver Rev, 2006, 58(15):1688-1713.
  • 5GERALD D J A, RAMSAY J R. Optimizing the lyophili- zation cycle and the consequences of collapse on the phar- maceutical acceptability of erwinia L-Asparaginase [J]. J Pharm Sci, 1996, 8606(12) :1301-1305.
  • 6YANG G GILSTRAP K, ZHANG A, et al. Collapse temperature of solutions important for lyopreservation of living cells at ambient temperature [J] Biotechnol Bio- eng, 2010, 106(2): 247-259.
  • 7BARRESI A A, PISANO R, FISSORE D, et al. Monito- ring of the primary drying of a lyophilization process in vials [J]. Chem Eng Process, 2009, 48(1 ): 408-423.
  • 8MEISTER E, SASIC S, GIESELER H. Freeze-dry mi- croscopy: impact of nucleation temperature and excipient concentration on collapse temperature data [ J ]. mAPS Pharm Sci Tech, 2009, 10(2) : 582-588.
  • 9PIKAL M J, SHAH S. The collapse temperature in freeze drying: dependence on measurement methodology and rate of water removal from the glassy phase [J]. Int J Pharm, 1990, 62(2-3): 165-186.
  • 10BARRESI A A, GHIO S, FISSORE D, et al. Freeze dr- ying of pharmaceutical excipients close to collapse tem- perature: influence of the process conditions on process time and product quality [J]. Dry Technol, 2009, 27 (6) :805-816.

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部